Company: ACBM
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001640334-25-001347
Chunk: 0

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-08-05
Form: 10-Q
Item: Item 1
Chunk 0
---
ACRO BIOMEDICAL CO., LTD.

Balance Sheets

(Unaudited)

  June 30,  December 31,   2025  2024        ASSETS      Current Assets      Cash $26  $476 Prepaid expenses  35,000   - Security deposit  4,600   4,600 Total Current Assets  39,626   5,076          Operating lease right of use asset  13,651   26,898 TOTAL ASSETS $53,277  $31,974          LIABILITIES AND STOCKHOLDERS' DEFICIT                 Current Liabilities        Accounts payable and accrued expenses $95,493  $154,460 Deferred revenue  20,000   20,000 Due to related parties  241,653   125,588 Operating lease liabilities - current  13,651   26,898 Total Current and Total Liabilities 370,797  326,946          Stockholders' Deficit        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding  -   - Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding  60,042   60,042 Additional paid-in capital  32,306,096   32,302,781 Accumulated deficit  (32,683,658)  (32,657,795)Total Stockholders’ Deficit  (317,520)  (294,972)         TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $53,277  $31,974 

The accompanying notes are an integral part of these unaudited financial statements.

 4Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Operations

(Unaudited)

  Three Months Ended   Six months ended   June 30,  June 30,   2025  2024  2025  2024              Revenues $-  $-  $-  $-                  Operating expenses                Selling, general and administrative